Author:
Soares da Costa Igor,Moreira Ricardo,Fernandes Hélder
Publisher
Springer International Publishing
Reference20 articles.
1. Altamura AC, Moliterno D, Paletta S, Maffini M, Maui MC, Bareggi S. Understanding the pharmacokinetics of anxiolytic drugs. Expert Opin Drug Metab Toxicol. 2013;9(4):423–40.
2. BIAL – Portela & Ca S.A. Sedoxil, 1 mg, tablet, summary of product characteristics. S. Mamede do Coronado; 2012.
3. Fernandes H, Moreira R. Mexazolam: clinical efficacy and tolerability in the treatment of anxiety. Neurol Ther. 2014;3(1):1–14.
4. Ferreira L, Figueira ML, Bessa-Peixoto A, Marieiro A, Albuquerque R, Paz C, Cerqueira A, Damião P, Dolgmer A, Dingemanse J. Psychomotor and anxiolytic effects of mexazolam in patients with generalised anxiety disorder. Clin Drug Investig. 2003;23(4):235–43.
5. Fukumizu T. Clinical experience with the new minor tranquilliser CS-386. Basic Pharmacol Ther. 1978;6:156–63.